BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 30922330)

  • 21. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
    Jung JH; Jung DB; Kim H; Lee H; Kang SE; Srivastava SK; Yun M; Kim SH
    Oncogene; 2018 Jul; 37(27):3715-3728. PubMed ID: 29628506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
    J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
    Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
    Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FBW7 suppresses ovarian cancer development by targeting the N
    Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
    Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype.
    Orben F; Lankes K; Schneeweis C; Hassan Z; Jakubowsky H; Krauß L; Boniolo F; Schneider C; Schäfer A; Murr J; Schlag C; Kong B; Öllinger R; Wang C; Beyer G; Mahajan UM; Xue Y; Mayerle J; Schmid RM; Kuster B; Rad R; Braun CJ; Wirth M; Reichert M; Saur D; Schneider G
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35439169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.
    Jiang H; Zhu Y; Zhou Z; Xu J; Jin S; Xu K; Zhang H; Sun Q; Wang J; Xu J
    Cancer Med; 2018 Mar; 7(3):869-882. PubMed ID: 29441724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.
    Li J; Rodriguez Y; Cheng C; Zeng L; Wong EYM; Xu CY; Zhou MM; Xu PX
    Mol Cell Biol; 2017 Jan; 37(1):. PubMed ID: 27795300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
    Jiang Y; Yuan Y; Chen M; Li S; Bai J; Zhang Y; Sun Y; Wang G; Xu H; Wang Z; Zheng Y; Nie H
    Theranostics; 2021; 11(18):9162-9176. PubMed ID: 34522232
    [No Abstract]   [Full Text] [Related]  

  • 31. Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis.
    Zhang M; Pan Y; Tang D; Dorfman RG; Xu L; Zhou Q; Zhou L; Wang Y; Li Y; Yin Y; Kong B; Friess H; Zhao S; Wu JL; Wang L; Zou X
    Cell Commun Signal; 2019 Mar; 17(1):23. PubMed ID: 30866966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
    Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
    Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
    Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine inhibits aerobic glycolysis in colorectal cancer cells by blocking the NMDA receptor-CaMK II-c-Myc pathway.
    Hu J; Duan W; Liu Y
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):848-856. PubMed ID: 31889340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor.
    Takada M; Zhuang M; Inuzuka H; Zhang J; Zurlo G; Zhang J; Zhang Q
    Oncotarget; 2017 Jan; 8(4):6787-6795. PubMed ID: 28036276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.
    Saha K; Eckert RL
    J Biol Chem; 2015 May; 290(21):13521-30. PubMed ID: 25851901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription.
    Fan Z; He L; Li M; Cao R; Deng M; Ping F; Liang X; He Y; Wu T; Tao X; Xu J; Cheng B; Xia J
    Neoplasia; 2020 Nov; 22(11):617-629. PubMed ID: 33045527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
    Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
    Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
    Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.